HUTCHMED (China) Limited (HCM)

Sector:

Pharma and Biotech

Index:

FTSE AIM 100

298.00p
   
  • Change Today:
    -8.00p
  • 52 Week High: 352.00
  • 52 Week Low: 192.40
  • Currency: UK Pounds
  • Shares Issued: 871.47m
  • Volume: 71,061
  • Market Cap: £2,596.98m
  • RiskGrade: 226

Regulatory News

Japan Approval for FRUZAQLA 24-Sep-2024 08:00 RNS
Total Voting Rights 30-Aug-2024 09:30 RNS
Update on Fruquintinib for Gastric Cancer in China 30-Aug-2024 07:00 RNS
Standard form for notification of major holdings 22-Aug-2024 09:30 RNS
LTIP and Share Option Scheme 06-Aug-2024 10:00 RNS
2024 Interim Results and Business Updates 31-Jul-2024 12:00 RNS
Blocklisting Six Monthly Return 28-Jun-2024 09:30 RNS
Total Voting Rights 28-Jun-2024 09:30 RNS
HUTCHMED to Announce 2024 HY Financial Results 26-Jun-2024 09:30 RNS
European Commission Approval for FRUZAQLA 24-Jun-2024 07:00 RNS
Total Voting Rights 31-May-2024 09:30 RNS
Retirement of Chairman and new Chairman appointed 17-May-2024 15:00 RNS
Result of AGM 10-May-2024 13:00 RNS
Directorate Change 08-May-2024 09:30 RNS
Positive CHMP Opinion for Fruquintinib 26-Apr-2024 13:30 RNS
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

HCM Market Data

Currency UK Pounds
Share Price 298.00p
Change Today -8.00p
% Change -2.61 %
52 Week High 352.00
52 Week Low 192.40
Volume 71,061
Shares Issued 871.47m
Market Cap £2,596.98m
RiskGrade 226

HCM Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
77.63% below the market average77.63% below the market average77.63% below the market average77.63% below the market average77.63% below the market average
48% below the sector average48% below the sector average48% below the sector average48% below the sector average48% below the sector average
Price Trend
72.66% above the market average72.66% above the market average72.66% above the market average72.66% above the market average72.66% above the market average
87.76% above the sector average87.76% above the sector average87.76% above the sector average87.76% above the sector average87.76% above the sector average
Income Not Available
Growth
69.25% above the market average69.25% above the market average69.25% above the market average69.25% above the market average69.25% above the market average
88.24% above the sector average88.24% above the sector average88.24% above the sector average88.24% above the sector average88.24% above the sector average

HCM Dividends

No dividends found

Trades for 03-Oct-2024

Time Volume / Share Price
16:35 15,444 @ 298.00p
16:35 185 @ 298.00p
16:35 14 @ 298.00p
16:35 130 @ 298.00p
16:35 306 @ 298.00p

HCM Key Personnel

Chair Dan Eldar
CEO Weiguo Su

Top of Page